title: Acute hippocampal sclerosis following ecstasy ingestion.
authors.affiliation: Department of Medicine, Northern Hospital, Epping, Victoria, Australia.
authors.forename: Helen
authors.initials: H
authors.lastname: Gardner
authors.forename: Nicholas
authors.initials: N
authors.lastname: Lawn
authors.forename: Daniel M
authors.initials: DM
authors.lastname: Fatovich
authors.forename: John S
authors.initials: JS
authors.lastname: Archer
mesh_terms: D018759:Adrenergic Uptake Inhibitors / Q000506:poisoning; D000328:Adult; D001284:Atrophy / Q000139:chemically induced* / Q000473:pathology; D001925:Brain Damage, Chronic / Q000139:chemically induced / Q000473:pathology / Q000503:physiopathology; D001928:Brain Diseases, Metabolic / Q000139:chemically induced* / Q000473:pathology / Q000503:physiopathology; D004829:Epilepsy, Generalized / Q000139:chemically induced / Q000503:physiopathology; D005260:Female; D006624:Hippocampus / Q000187:drug effects* / Q000473:pathology; D006801:Humans; D008279:Magnetic Resonance Imaging; D008297:Male; D018817:N-Methyl-3,4-methylenedioxyamphetamine / Q000506:poisoning*; D018490:Serotonin Agents / Q000506:poisoning; D013995:Time
chemical_list: D018759:Adrenergic Uptake Inhibitors; D018490:Serotonin Agents; D018817:N-Methyl-3,4-methylenedioxyamphetamine